Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG
DGAP-News: Epigenomics AG
/ Key word(s): Miscellaneous/AGM/EGM
Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG
Pursuant to Sec. 92 par. 1 German Stock Corporation Act ("Aktiengesetz"), a loss amounting to half of the nominal share capital triggers the statutory obligation to convene without undue delay a general meeting of shareholders which the Executive Board notifies of the loss. Accordingly, the Company will convene in due time an extraordinary general meeting of shareholders.
Investor Relations
This communication expressly or implicitly contains certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any expected results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
26.10.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Epigenomics AG |
Geneststraße 5 | |
10829 Berlin | |
Germany | |
Phone: | +49 30 24345-0 |
Fax: | +49 30 24345-555 |
E-mail: | ir@epigenomics.com |
Internet: | www.epigenomics.com |
ISIN: | DE000A11QW50 |
WKN: | A11QW5 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1142913 |
End of News | DGAP News Service |
Editor Details
-
Company:
- EQS Newsfeed
- Website: